Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03740529 |
Title | A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Loxo Oncology, Inc. |
Indications |
chronic lymphocytic leukemia/small lymphocytic lymphoma |
Therapies |
Cyclophosphamide + Doxorubicin + LOXO-305 + Prednisone + Rituximab + Vincristine Sulfate |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | FRA |